Learning About Chronic Lymphocytic Leukemia | Lymph Notes: A Lymphoma Learning Series

Matthew Davids, MD, MMSc, and Inhye Ahn, MD, share updates on recent advancements and treatment options for patients with chronic lymphocytic leukemia (CLL). Dr. Davids discusses treatment considerations for newly-diagnosed patients, and Dr. Ahn discusses treatment for relapsed and refractory patients. In addition, learn about a patient’s personal journey with CLL, why they chose Dana-Farber, and their experience participating in a clinical trial in a discussion led by Jennifer Brown, MD, PhD. Lastly, Austin Kim, MD, answers questions about about clinical trials and patient experiences. To learn more about Dana-Farber's CLL Center, visit https://www.dana-farber.org/cancer-care/treatment/hematologic-oncology/programs/chronic-lymphocytic-leukemia